Hori's nevus
| Hori's nevus | |
|---|---|
| Synonyms | Acquired bilateral nevus of Ota-like macules |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Blue-gray to brown patches on the face, particularly on the cheeks, forehead, and nose |
| Complications | Cosmetic concerns |
| Onset | Adulthood |
| Duration | Chronic |
| Types | N/A |
| Causes | Unknown, possibly genetic and environmental factors |
| Risks | More common in Asian populations, particularly Japanese |
| Diagnosis | Clinical examination |
| Differential diagnosis | Nevus of Ota, Melasma, Mongolian spot |
| Prevention | N/A |
| Treatment | Laser therapy, such as Q-switched laser |
| Medication | N/A |
| Prognosis | N/A |
| Frequency | Relatively uncommon |
| Deaths | N/A |
Hori's nevus, also known as acquired bilateral nevomelanocytic nevus or ABNOM, is a type of melanocytic nevus characterized by its acquired nature and symmetrical distribution on the face. Unlike congenital melanocytic nevi, Hori's nevus develops later in life, typically in adult women, and is more common in individuals of Asian descent. This condition is considered benign, but it can cause cosmetic concerns due to its appearance.
Etiology and Pathogenesis[edit]
The exact cause of Hori's nevus is not fully understood, but it is believed to be multifactorial. Genetic predisposition, hormonal influences, and sun exposure are thought to play roles in its development. The lesions of Hori's nevus contain an increased number of melanocytes and melanin, suggesting an overactivity of melanin-producing cells in the affected areas.
Clinical Features[edit]
Hori's nevus presents as symmetrical, blue-gray or brown patches on the face, especially on the cheeks, nose, and forehead. The lesions are usually flat and do not exhibit textural changes. They tend to appear in adulthood, with a higher prevalence in women, suggesting a possible hormonal influence. Although Hori's nevus is asymptomatic, its appearance can lead to psychological distress in affected individuals.
Diagnosis[edit]
Diagnosis of Hori's nevus is primarily clinical, based on the characteristic appearance of the lesions. Dermoscopy can aid in the diagnosis by revealing specific patterns, such as a homogenous blue-gray pigmentation. In uncertain cases, a biopsy may be performed to rule out other pigmented lesions and confirm the diagnosis histologically.
Treatment[edit]
Treatment of Hori's nevus is challenging and primarily aimed at cosmetic improvement. Options include laser therapy, such as Q-switched lasers, which can be effective in lightening the lesions. Other treatments, such as chemical peels and topical bleaching agents, have been used with varying degrees of success. It is important for patients to have realistic expectations and understand that complete removal may not be possible.
Prognosis[edit]
The prognosis for Hori's nevus is generally good, as it is a benign condition. However, the cosmetic impact can be significant, and some individuals may experience psychological distress due to the appearance of the lesions. Treatment can improve the cosmetic appearance but may require multiple sessions and ongoing maintenance.
Prevention[edit]
There are no specific measures to prevent Hori's nevus, but minimizing sun exposure and using sunscreen may help reduce the risk of developing pigmented lesions. Individuals with a family history of Hori's nevus or other pigmented disorders should be particularly cautious about sun protection.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian